Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01932788 · ClinicalTrials.gov registry record · Phase 3
Preventing Health Disparities During Pregnancy Through Vitamin D Supplementation
A Phase 3 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 3
- Development phase
- 342
- Enrollment target
NCT01932788 is a Phase 3 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 342 participants.
The verdict
NCT01932788, a Phase 3 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 342 participants
- Enrollment target
Study Summary
The purpose of this study is to give all mothers the best chance for a healthy pregnancy through vitamin D supplementation. We will study women of diverse racial/ethnic backgrounds who will receive either the current vitamin D standard of 400 IU/day (in the prenatal vitamin) or 4000 IU/day (dose found in previous pregnancy studies to achieve vitamin D sufficiency). This research is sponsored by the W.K. Kellogg Foundation and the Medical University of South Carolina. The purpose of this study is to examine the effectiveness and infection-fighting properties of the body in relationship to vitamin D levels. This study is being done at the Medical University of South Carolina (MUSC) clinics, and will involve approximately 450 volunteers.
Interventions
- DRUG Vitamin D3 4000 IU in gummy form
- DRUG Placebo gummy vitamin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-04-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01932788
The ClinicalTrials.gov registry entry for NCT01932788 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 4000 IU in gummy form is the first listed.
NCT01932788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01932788 about?
NCT01932788 is a clinical study titled "Preventing Health Disparities During Pregnancy Through Vitamin D Supplementation". The purpose of this study is to give all mothers the best chance for a healthy pregnancy through vitamin D supplementation. We will study women of diverse racial/ethnic backgrounds who will receive either the current vitamin D standard of 400 IU/day (in the prenatal vitamin) or 4000 IU/day (dose fou...
What is the current status of trial NCT01932788?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 342 participants. The study started on 2013-01. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT01932788?
The interventions under investigation include: Vitamin D3 4000 IU in gummy form (DRUG), Placebo gummy vitamin (DRUG).
Who is sponsoring clinical trial NCT01932788?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.